Distinguishing Choroidal Nevi from Melanomas Using the MOLES Algorithm: Evaluation in an Ocular Nevus Clinic.

IF 0.9 Q4 OPHTHALMOLOGY
Ocular Oncology and Pathology Pub Date : 2021-09-01 Epub Date: 2021-03-15 DOI:10.1159/000511363
Lamis Al Harby, Mandeep S Sagoo, Roderick O'Day, Gordon Hay, Amit K Arora, Pearse A Keane, Victoria M-L Cohen, Bertil Damato
{"title":"Distinguishing Choroidal Nevi from Melanomas Using the MOLES Algorithm: Evaluation in an Ocular Nevus Clinic.","authors":"Lamis Al Harby,&nbsp;Mandeep S Sagoo,&nbsp;Roderick O'Day,&nbsp;Gordon Hay,&nbsp;Amit K Arora,&nbsp;Pearse A Keane,&nbsp;Victoria M-L Cohen,&nbsp;Bertil Damato","doi":"10.1159/000511363","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to determine the sensitivity and specificity of the MOLES scoring system in differentiating choroidal melanomas from nevi according to Mushroom shape, Orange pigment, Large tumor size, Enlarging tumor, and Subretinal fluid (SRF).</p><p><strong>Methods: </strong>Color photographs, fundus-autofluorescence images, and optical coherence tomography of 222 melanocytic choroidal tumors were reviewed. Each MOLES feature was retrospectively scored between 0 and 2 and tumors categorized as \"common nevus,\" \"low-risk nevus,\" \"high-risk nevus,\" and \"probable melanoma\" according to the total score. MOLES scores were compared with the experts' diagnosis of melanoma.</p><p><strong>Results: </strong>The MOLES scoring system indicated melanoma in all 81 tumors diagnosed as such by ocular oncologists (100% sensitivity) and nevus in 135 of 141 tumors given this diagnosis by these experts (95.7% specificity). Of the 6 tumors with discordant diagnoses, 4 had basal diameters exceeding 6 mm, all with SRF and/or orange pigment, and 2 small tumors showed either significant SRF with traces of orange pigment, or vice versa.</p><p><strong>Conclusions: </strong>The MOLES system for diagnosing melanocytic choroidal tumors compares well with expert diagnosis but needs to be evaluated when deployed by ophthalmologists and community optometrists in a wide variety of working environments.</p>","PeriodicalId":19434,"journal":{"name":"Ocular Oncology and Pathology","volume":"7 4","pages":"294-302"},"PeriodicalIF":0.9000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000511363","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Oncology and Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000511363","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/3/15 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 14

Abstract

Objective: The aim of this study was to determine the sensitivity and specificity of the MOLES scoring system in differentiating choroidal melanomas from nevi according to Mushroom shape, Orange pigment, Large tumor size, Enlarging tumor, and Subretinal fluid (SRF).

Methods: Color photographs, fundus-autofluorescence images, and optical coherence tomography of 222 melanocytic choroidal tumors were reviewed. Each MOLES feature was retrospectively scored between 0 and 2 and tumors categorized as "common nevus," "low-risk nevus," "high-risk nevus," and "probable melanoma" according to the total score. MOLES scores were compared with the experts' diagnosis of melanoma.

Results: The MOLES scoring system indicated melanoma in all 81 tumors diagnosed as such by ocular oncologists (100% sensitivity) and nevus in 135 of 141 tumors given this diagnosis by these experts (95.7% specificity). Of the 6 tumors with discordant diagnoses, 4 had basal diameters exceeding 6 mm, all with SRF and/or orange pigment, and 2 small tumors showed either significant SRF with traces of orange pigment, or vice versa.

Conclusions: The MOLES system for diagnosing melanocytic choroidal tumors compares well with expert diagnosis but needs to be evaluated when deployed by ophthalmologists and community optometrists in a wide variety of working environments.

Abstract Image

用痣算法区分脉络膜痣与黑色素瘤:眼部痣临床评价。
目的:本研究的目的是确定MOLES评分系统根据蘑菇形状、橙色色素、大肿瘤大小、肿瘤扩大和视网膜下液(SRF)区分脉络膜黑色素瘤和痣的敏感性和特异性。方法:对222例脉络膜黑色素细胞肿瘤的彩色照片、眼底自发荧光图像和光学相干断层扫描进行回顾性分析。MOLES的每个特征都进行了0到2分的回顾性评分,根据总分将肿瘤分为“常见痣”、“低风险痣”、”高风险痣“和”可能的黑色素瘤“。将MOLES评分与专家对黑色素瘤的诊断进行比较。结果:MOLES评分系统显示,眼部肿瘤学家诊断的所有81个肿瘤中都有黑色素瘤(敏感性100%),这些专家诊断的141个肿瘤中有135个肿瘤有痣(特异性95.7%)。在6个诊断不一致的肿瘤中,4个肿瘤的基底直径超过6毫米,均带有SRF和/或橙色色素,2个小肿瘤显示出明显的SRF和微量橙色色素,反之亦然。结论:诊断黑色素细胞脉络膜肿瘤的MOLES系统与专家诊断相比效果良好,但需要由眼科医生和社区验光师在各种工作环境中进行评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
0.00%
发文量
20
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信